Comet Therapeutics Inc.
Industry
- Pharmaceuticals
- Biotechnology
See more in Biomedtracker
Latest on Comet Therapeutics Inc.
Scrip
• By Kevin Grogan
Having just raised $125m and presented promising mid-stage data on apraglutide, VectivBio Holding AG is making strides in its bid to become the leading player in the short bowel syndrome (SBS) space
Scrip
• By Alaric DeArment
Who: VectivBio Holding AG and Comet Therapeutics Inc. What: On 31 August, Basel, Switzerland-based VectivBio said it would acquire Cambridge, MA-based Comet, a company focused on developing sma